News and Stories

It started in the early 1990s as a registry of patients with a heart condition. Today, data from more than 2,000 families with dilated cardiomyopathy is informing the next generation of therapies for this serious disease.

Together, cardiologist Luisa Mestroni, MD, and geneticist Matthew Taylor, MD, PhD, both professors in the Division of Cardiology at the University of Colorado School of Medicine, have helped thousands of patients in the clinic. They’ve also studied many of the over 50 genes associated with dilated cardiomyopathy (DCM). In the following Q&A, they explain their research and the gene therapy clinical trials that will be launching on the CU Anschutz Medical Campus during the first half of 2024.

Guest Contributor | February 20, 2024

At the fall Block Party, when the center of campus erupted into a mass of people, booths and food trucks, some partygoers might have noticed an unusual guest milling around. An oversized sperm, waving and weaving through the lines of people, turned more than a few heads at the annual event.

Debra Melani | January 10, 2024

As the holiday and peak respiratory seasons collide, and COVID-19 cases continue a steady, weeks-long climb, doctors want high-risk people to remember: Should COVID catch them in the coming days, one call to the doctor could save Christmas – or more.

Debra Melani | December 05, 2023

University of Colorado Anschutz Medical Campus researchers are part of an international team that has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage.

Laura Kelley | November 27, 2023

With the largest universal screening programs in the country, researchers at the Barbara Davis Center for Diabetes (BDC) have known for years that testing all children for type 1 diabetes (T1D) could prevent the heartbreak and life-threatening complications that late-stage diagnosis can cause. Yet, until recently, they have often felt alone in their educational efforts.

Debra Melani | November 22, 2023

Celiac disease is an autoimmune disorder that damages the small intestine when gluten, a protein found in wheat, barley and rye, is ingested. According to a recent study published in The American Journal of Gastroenterology, the worldwide incidence rate among children is “extremely high,” but varies by region.

Guest Contributor | November 17, 2023

At its given pace, colorectal cancer will seize the No. 1 spot as the top killer of Americans aged 20 to 49 within seven years. Cases of the deadly cancer – its warning signs not often comfortably shared with friends or even doctors – have increased between 1% and 2% each year in that age group since 1990.

Staff | September 14, 2023

Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).

Laura Kelley | August 03, 2023

Between leading-edge research and the region’s first clinic to specialize in treating patients with long COVID symptoms, the University of Colorado Anschutz Medical Campus is at the forefront of providing care while seeking to understand this still-mysterious disease. 

Chris Casey | July 11, 2023

Research in health equity and social determinants seeks to understand disparities and affect real change, yet the national data collection systems investigators rely on for their work are incomplete and hardwired for structural racism, Shale Wong, MD, MSPH, told attendees of the 10th annual Colorado Clinical and Translational Sciences Institute academic summit on Sept. 14.

Guest Contributor | September 19, 2022

As the nation reels from a substance abuse crisis that’s shattering lives every day, scientists and clinicians across the University of Colorado Anschutz Medical Campus work diligently in their labs and clinics, hoping to prevent tragedies of addiction.

Debra Melani | September 19, 2022

Family, friends and positive attitudes helped Katherine Haug through months of failed attempts at ridding her body of cancer. Then a passionate doctor with an experimental treatment gave the wife, mother and grandmother a big reason to smile.

Debra Melani | August 15, 2022

Researchers at the University of Colorado Anschutz Medical Campus have shown a direct link between vagus nerve stimulation and its connection to the learning centers of the brain. The discovery may lead to treatments that will improve cognitive retention in both healthy and injured nervous systems.

Laura Kelley | July 28, 2022

A 25% jump in alcohol-associated deaths in the United States in 2020 doesn’t surprise Joseph Schacht, PhD. The clinical psychologist and neuroscientist at the University of Colorado Anschutz Medical Campus, who specializes in the treatment of alcohol and other addictive disorders, has seen an increase in patients whose drinking rose during the pandemic.

Laura Kelley | April 05, 2022

Artin (Art) Shoukas, PhD, a Johns Hopkins University professor emeritus, would have never dreamed he’d be using marijuana every night in his retirement years. He melts the medicinal form – mostly cannabidiol (CBD) with just a touch of tetrahydrocannabinol (THC) – under his tongue before dinner.

Debra Melani | February 10, 2022

The University of Colorado Anschutz Medical Campus – home to Children’s Hospital Colorado, UCHealth University of Colorado Hospital and the CU School of Medicine – has been designated as a NORD Rare Disease Center of Excellence for its research and commitment to advance care for patients with rare diseases.

Staff | February 08, 2022

Scientists at the University of Colorado School of Medicine, along with colleagues at UCHealth University of Colorado Hospital, have discovered specific genetic biomarkers that not only show who is infected with COVID-19, but offer insights into how severe the disease might be, filling a major diagnostic gap.

David Kelly | October 26, 2021

As controversy swirls around the first disease-modifying Alzheimer’s drug ever approved, top experts at the University of Colorado Anschutz Medical Campus see the move – for the most part – as a step forward.

Debra Melani | June 15, 2021